Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

Opioid rotation for toxicity reduction in terminal cancer patients

Noe ́mi D. de Stoutz, Eduardo Bruera, María E. Suarez‐Almazor · Journal of Pain and Symptom Management · 1995 · 386 citations

Medicine, Oncology, Pharmacology +17

The memorial pain assessment card. A valid instrument for the evaluation of cancer pain

Baruch Fishman, Sara Pasternak, Stanley L. Wallenstein et al. · Cancer · 1987 · 331 citations · Full text

Medicine, Oncology, Cancer Pain Management +16

Multicentre study of cancer pain and its treatment in France

François Larue, Sophie M. Colleau, Charles S. Cleeland · BMJ · 1995 · 328 citations

Medicine, Oncology, Pharmacotherapy +15

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

Barbara Donner, M. Zenz, M. Tryba et al. · Pain · 1996 · 263 citations

Medicine, Oncology, Pharmacology +17